Home › News › Clinical Trials › Archive

Clinical Trial News Archive

Get news By email or subscribe to our News feeds.

All News Consumer Pharma New Drugs Pipeline Clinical Trials

January 2007

January 9

ImClone Systems to Disclose the Result of a Phase III Study before End of Week Incyte to Report Positive Preliminary Clinical Results from HIV and Diabetes Programs and Highlight Progress in Several Drug Development Programs at the 25th JPMorgan Healthcare Conference Dynavax Reports Interim Tolamba Ragweed Allergy Results From DARTT Trial XenoPort Announces Advancements in Clinical Development Programs Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of Fentora in Breakthrough Pain QuatRx Pharmaceuticals Reports Positive Results From a Phase 2 Trial of Fispemifene Myriad Genetics Announces Results of Phase 2 Prostate Cancer Trial ProtoKinetix Highlights AAGP Development and Production Strategy ProEthic Pharmaceuticals Announces Positive Phase III Clinical Trial Results for Fast-Acting Migraine Product Candidate Neurocrine Biosciences Announces Positive Results From Second Phase II Study With Its Orally Active GnRH Receptor Antagonist in Endometriosis Quigley's Broad Spectrum Anti-Viral QR-441(a) Shown to Be Effective Against Two Problematic Pathogens to the Poultry Industry Herceptin Improves Early Survival for Women with Breast Cancer

January 11

SemBioSys' Plant-Produced Insulin Chemically and Physiologically Equivalent to Commercial Insulin in Animal Studies Erbitux Meets Primary Endpoint in First-Line Phase III Metastatic Colorectal Cancer Study Basilea Announces Positive Top-Line Results On Second Pivotal Phase III Ceftobiprole Trial Erbitux Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer Oncolytics Biotech Inc. Research Collaborators to Present Reovirus Data at Society of Academic & Research Surgery Conference Oncolytics Biotech Inc. Research Collaborators to Present Reovirus Data at Society of Academic & Research Surgery Conference APR Announces Today Successful Phase III Clinical Trial Results for PRO-513 Basilea Announces Positive Top-line Results on Second Pivotal Phase III Ceftobiprole Trial

January 12

Chelsea Therapeutics Announces Results of European Phase IIb Trial of Droxidopa MultiCell Technologies' Proprietary Breakthrough Anti-Cancer Therapy Shown to Prevent Recurrence of Cancer Bayer and Onyx Announce Pivotal Nexavar Kidney Cancer Study Published in New England Journal of Medicine New England Journal of Medicine Reports Aegerion's Lead Compound Reduces LDL By 51% in Patients With a Severe Form of Hypercholesterolemia New England Journal of Medicine Reports Aegerion's Lead Compound Reduces LDL By 51% in Patients With a Severe Form of Hypercholesterolemia Nutra Pharma Announces Breakthrough Research in the Treatment of Viral Infections Positive Results with Rotigotine in Restless Legs Syndrome in Second Phase III Trial Women's Response to Anti-HIV Therapy Improved if Treatment Begins Six Months After Earlier Preventive Regimen

January 17

Merrion Announces Positive Clinical Results for Osteoporosis Drug MER 103 Hollis-Eden Pharmaceuticals Presents Data Demonstrating Discovery of an Endogenous Hormone Potentially Central to Glucose Metabolism ArQule Provides Clinical Trial Update Viragen Announces That OVA System Results are Published in Leading U.S. Scientific Journal Merck Serono Announces Positive Results From Phase III Diet Study of Phenoptin for Phenylketonuria BioMarin Announces Positive Results From Phase 3 Diet Study of Phenoptin for PKU Watson Announces Positive Phase 3 Study Results on Silodosin for Treatment of Benign Prostatic Hyperplasia Watson Announces Positive Phase 3 Study Results on Silodosin for Treatment of Benign Prostatic Hyperplasia MediciNova Announces Results From a Phase II/III Interstitial Cystitis Trial With MN-001 Combination of Introgen's Nanoparticles Demonstrate Increased Efficacy in the Treatment of Metastatic Lung Cancer African-American Heart Attack Survivors Cite Experience as a 'Wake-Up Call' to Address Health and Life Issues Pivotal Paper in 'The Oncologist' From National Cancer Institute Predicts Doubling of Cancer Patients Study Finds Antivirals Effectively Curb Influenza Virus and Are Valuable in Managing Seasonal Flu in Households

January 23

Results Show Xelox (Xeloda plus oxaliplatin) Provides Equivalent Overall Patient Survival Compared to Folfox in Advanced Colorectal Cancer Cell Genesys Announces Encouraging Follow-Up Survival Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer Quigley QR-443 Cachexia Compound Demonstrates Dose Response Effectiveness in Second Preliminary Animal Model Study; Oral Dosing of QR-443 Equally Effective to Intra-Peritoneal Administration in Delaying the Progression of Cachexia in Preliminary Tumor Burden Mouse Model Halozyme Therapeutics Releases Results of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large Protein Molecule Therapeutic BTG's Plevitrexed Shows Promising Efficacy and Tolerability in a Phase I/II study Bioponic Phytoceuticals Announces That Its Curecumin Product May Be an Effective Treatment for Alzheimer's Disease Infinity and MedImmune Provide Update On Phase I GIST Trial for IPI-504, a Novel Hsp90 Inhibitor Chemokine Therapeutics to Present Data at the Annuual Meeting of the American Association For Cancer Research on its Lead Drug Candidate, CTCE-9908 Pharmos Announces Clinical Data from Phase 2a Trial of Cannabinor for Capsaicin-induced Pain New Study Evaluates Communication About Chemotherapy-Induced Anemia and Fatigue in Clinical Settings Callisto Pharmaceuticals Announces Publication of Research Paper on Atiprimod Introgen's ADVEXIN Clinical Biomarker Data Presented at Conference on Licensure of Cell and Gene Therapy Products Welichem's Anti-cancer Drug Candidate Stimulates the Immune System Report Finds Over-the-Counter Drug for Heartburn, Acid Reflux as Effective as Prescription Drugs Costing 10 Times More

January 26

European Association of Nuclear Medicine Journal Article Reports New Data Regarding Administration of Quadramet with Chemotherapy in Hormone Refractory Prostate Cancer Patients The New England Journal Of Medicine Publishes Two Landmark Studies Of Noxafil (Posaconazole) in the Prevention of Invasive Fungal Infections Chopping Off Protein Puts Immune Cells Into High Gear Altea Therapeutics Announces Positive Clinical Results for its Basal Insulin Transdermal Patch Chromos Reports Preclinical Data in Support of CHR-1103 as an Acute Therapy for Relapse Associated with Multiple Sclerosis DOR BioPharma to Host Conference Call on Thursday, January 25 to Discuss Recently Published orBec(R) Phase 3 Clinical Results Cephalon and National Cancer Institute Report Improved Survival in Newly Diagnosed Adult Patients with Acute Promyelocytic Leukemia in Study Using Trisenox Arsenic Compound Improves Survival of Adults with Uncommon Form of Leukemia Study Suggests Thrombolysis Therapy with Alteplase Could Be Used Routinely for Stroke Treatment Samaritan Pharma's SP-10 Hip On Hep C

Clinical Trial Results Archive

2005

April

More News Resources

(web2)